Avanos Medical, Inc. Forecast, price target & analysts
Avanos Medical, Inc. Target price 2024 - Analyst rating & recommendation
Avanos Medical, Inc. Classifications & Recommendation:
Avanos Medical, Inc. Price Target
| Target Price | $20.00 |
| Price | $15.92 |
| Potential |
25.63%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Avanos Medical, Inc. price target 2025.
The average Avanos Medical, Inc. target price is $20.00.
This is
25.63%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend Avanos Medical, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Avanos Medical, Inc. stock has an average upside potential 2025 of
25.63%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 673.30 | 685.45 |
| 1.58% | 1.80% |
2 Analysts have issued a sales forecast Avanos Medical, Inc. 2024 . The average Avanos Medical, Inc. sales estimate is
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | 1.23 |
Based on analysts' sales estimates for 2024, the Avanos Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Avanos Medical, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
